<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Regencell Bioscience Holdings Limited — News on 6ix</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd</link>
<description>Latest news and press releases for Regencell Bioscience Holdings Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 12 Sep 2022 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/regencell-bioscience-holdings-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b76a78dffbe2df114864.webp</url>
<title>Regencell Bioscience Holdings Limited</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd</link>
</image>
<item>
<title>Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-biosciences-standardized-formulae-are-shown-to-reduce-adhd-and-asd-symptoms</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-biosciences-standardized-formulae-are-shown-to-reduce-adhd-and-asd-symptoms</guid>
<pubDate>Mon, 12 Sep 2022 04:00:00 GMT</pubDate>
<description>- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body</description>
</item>
<item>
<title>Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-announces-additional-earth-efficacy-trial-results-corroborating</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-announces-additional-earth-efficacy-trial-results-corroborating</guid>
<pubDate>Wed, 18 May 2022 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial EARTH Efficacy Trials Period of trial 30</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-over-dollar5-million-ordinary-share</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-over-dollar5-million-ordinary-share</guid>
<pubDate>Mon, 16 May 2022 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing</description>
</item>
<item>
<title>Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-describes-their-traditional-chinese-medicine-tcm-treatments-and-recent</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-describes-their-traditional-chinese-medicine-tcm-treatments-and-recent</guid>
<pubDate>Tue, 01 Mar 2022 05:00:00 GMT</pubDate>
<description>LOS ANGELES, CA / ACCESSWIRE / March 1, 2022 / SNN Network, The Official Small-, Micro- and Nano-Cap News Source™, today published a new Video Interview with</description>
</item>
<item>
<title>Regencell Bioscience’s Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-biosciences-investigational-liquid-formula-rgc-cov19tm-shows-effectiveness</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-biosciences-investigational-liquid-formula-rgc-cov19tm-shows-effectiveness</guid>
<pubDate>Wed, 16 Feb 2022 05:00:00 GMT</pubDate>
<description>36 out of 37 COVID-19 patients treated in the trial, representing approximately 97.3% of the patients, reported they had all symptoms eliminated within the</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-appoints-dr-william-wing-yan-lo-jp-to-its</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-appoints-dr-william-wing-yan-lo-jp-to-its</guid>
<pubDate>Mon, 13 Dec 2021 05:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-over-dollar1-million-ordinary-share</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-over-dollar1-million-ordinary-share</guid>
<pubDate>Mon, 22 Nov 2021 05:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-included-in-the-msci-world-micro-cap-index-2021</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-included-in-the-msci-world-micro-cap-index-2021</guid>
<pubDate>Mon, 22 Nov 2021 05:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focuses on</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-establishes-a-joint-venture-to-offer-covid</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-establishes-a-joint-venture-to-offer-covid</guid>
<pubDate>Thu, 02 Sep 2021 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), today announced that Regencell Bioscience</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-partial-exercise-of-underwriters-over</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-partial-exercise-of-underwriters-over</guid>
<pubDate>Fri, 20 Aug 2021 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ:RGC) ("Regencell" or the "Company"), an early-stage bioscience company that</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-releases-ceo-letter-to-shareholders-2021-08-05</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-releases-ceo-letter-to-shareholders-2021-08-05</guid>
<pubDate>Thu, 05 Aug 2021 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company today</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-closing-of-initial-public-offering</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-closing-of-initial-public-offering</guid>
<pubDate>Tue, 20 Jul 2021 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that</description>
</item>
<item>
<title>Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering</title>
<link>https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-pricing-of-approximately-dollar219</link>
<guid isPermaLink="true">https://6ix.com/company/regencell-bioscience-holdings-ltd/news/regencell-bioscience-holdings-limited-announces-pricing-of-approximately-dollar219</guid>
<pubDate>Thu, 15 Jul 2021 04:00:00 GMT</pubDate>
<description>HONG KONG--(BUSINESS WIRE)-- Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that</description>
</item>
</channel>
</rss>